ArticleOncology letters2018

Enhancement of cisplatin cytotoxicity by Retigeric acid B involves blocking DNA repair and activating DR5 in prostate cancer cells.

Yongqing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.